you are here: HomeNewsWorld

COVID-19 Vaccines Update: India-Japan discuss ‘concrete steps’ for Quad initiative: Report

Issues such as possible Quad mechanism for emergency vaccine supply in crisis situations and sources of finance for procurement and distribution were discussed in the meets

June 08, 2021 / 01:29 PM IST
The ‘Quad initiative’ as it is dubbed – will fund vaccine production in the Indo-Pacific region and the two key meetings held in May were in regards to “modalities for funding” (Image Source: Shutterstock)

The ‘Quad initiative’ as it is dubbed – will fund vaccine production in the Indo-Pacific region and the two key meetings held in May were in regards to “modalities for funding” (Image Source: Shutterstock)

India and Japan are discussing “concrete suggestions” to take the Quadrilateral vaccine initiative forward and manufacture COVID-19 vaccines as agreed in March.

The ‘Quad initiative’ as it is dubbed – will fund vaccine production in the Indo-Pacific region and the two key meetings held in May were in regards to “modalities for funding”, The Economic Times reported.

May 27, had top officials for vaccine manufacturing and supply from the Indian government including officials from the Department of Biotechnology (DBT) and Ministry of External Affairs (MEA), and from Japan Bank for International Cooperation (JBIC).

Moneycontrol could not independently verify the report.

Follow our LIVE blog on the COVID-19 pandemic here

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Issues such as possible Quad mechanism for emergency vaccine supply in crisis situations and sources of finance for procurement and distribution were discussed in the meets, it added.

Sources told the paper that it was decided that the DBT will facilitate JBIC’s talks with interested vaccine manufacturers for direct funding, similar to the United States International Development Finance Corporation’s (DFC) funding of 1 billion vaccine doses by Hyderabad-based Biological E, which was announced in March.

The White House, in a statement on March 12 had said the Quad was “working collaboratively to expand manufacturing of safe and effective COVID-19 vaccines at facilities in India, prioritising increased capacity for vaccines authorised by Stringent Regulatory Authorities”.

For full coverage on the coronavirus pandemic click here
Moneycontrol News
first published: Jun 8, 2021 01:29 pm

stay updated

Get Daily News on your Browser
Sections
ISO 27001 - BSI Assurance Mark